Up until recently, investors knew that plant biotechnology company 22nd Century Group (NASDAQ: XXII) was in both the tobacco and cannabis industries, plus another unnamed sector (which it initially alluded to last year). On Aug. 30, the company finally unveiled what that last business was: specialty hops. It's down by more than 35% in the past three months (the S&P 500 has risen 5% during that period) and the company is consistently incurring losses, meaning investors still need to be careful with 22nd Century Group as it could be awhile before its financials improve.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting